GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » EV-to-FCF

Jenscare Scientific Co (HKSE:09877) EV-to-FCF : -2.97 (As of Apr. 11, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Jenscare Scientific Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jenscare Scientific Co's Enterprise Value is HK$954.38 Mil. Jenscare Scientific Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-321.01 Mil. Therefore, Jenscare Scientific Co's EV-to-FCF for today is -2.97.

The historical rank and industry rank for Jenscare Scientific Co's EV-to-FCF or its related term are showing as below:

HKSE:09877' s EV-to-FCF Range Over the Past 10 Years
Min: -2.97   Med: 0   Max: 0
Current: -2.97

HKSE:09877's EV-to-FCF is ranked worse than
100% of 387 companies
in the Medical Devices & Instruments industry
Industry Median: 22.93 vs HKSE:09877: -2.97

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-11), Jenscare Scientific Co's stock price is HK$3.90. Jenscare Scientific Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.461. Therefore, Jenscare Scientific Co's PE Ratio (TTM) for today is At Loss.


Jenscare Scientific Co EV-to-FCF Historical Data

The historical data trend for Jenscare Scientific Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenscare Scientific Co EV-to-FCF Chart

Jenscare Scientific Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
- - -114.75 -24.61 -

Jenscare Scientific Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only -114.75 - -24.61 - -

Competitive Comparison of Jenscare Scientific Co's EV-to-FCF

For the Medical Devices subindustry, Jenscare Scientific Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jenscare Scientific Co's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Jenscare Scientific Co's EV-to-FCF falls into.


;
;

Jenscare Scientific Co EV-to-FCF Calculation

Jenscare Scientific Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=954.379/-321.01
=-2.97

Jenscare Scientific Co's current Enterprise Value is HK$954.38 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-321.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jenscare Scientific Co  (HKSE:09877) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Jenscare Scientific Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.90/-0.461
=At Loss

Jenscare Scientific Co's share price for today is HK$3.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.461.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Jenscare Scientific Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Jenscare Scientific Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jenscare Scientific Co Business Description

Traded in Other Exchanges
N/A
Address
No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Executives
Li Hui 2501 Other
Trident Trust Company (hk) Limited 2301 Trustee
Trinity Elite I International Limited 2201 Interest of corporation controlled by you
Lv Shiwen 2501 Other
Ningbo Dixiang Venture Capital Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Shidi Industrial Development Co., Ltd. 2501 Other
Pan Fei 2201 Interest of corporation controlled by you
Shanghai Jiachen Investment Co.,ltd 2201 Interest of corporation controlled by you
Ningbo Sangdi Investment Management L.p. (limited Partnership) 2101 Beneficial owner
Ningbo Linfeng Biotechnology Co., Ltd. 2101 Beneficial owner
Hainan Yize Medical Technology Co., Limited 2201 Interest of corporation controlled by you
Hainan Maidi Enterprise Management L.p. (limited Partnership) 2101 Beneficial owner
Hainan Hualing Investment L.p. (limited Partnership) 2101 Beneficial owner
Hangzhou Chende Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Mukang Venture Capital Partnership (limited Partnership)

Jenscare Scientific Co Headlines

No Headlines